Position in OGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$245,954
-$191,709 QoQ
Shares Held
18,165
+15.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#224
of 625 holders
Holding Since
Dec 2022
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empirical Asset Management, LLC holds $14,808,473 across 9 Drug Manufacturers - General names. OGN ranks #9 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,661 | $5,590,543 | |
| 2 | JNJ |
Johnson & Johnson
|
8,572 | $2,177,030 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,535 | $1,996,247 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
13,735 | $1,735,279 | |
| 5 | ABBV |
AbbVie Inc.
|
5,575 | $1,402,893 | |
| 6 | AMGN |
Amgen Inc
|
2,925 | $1,059,201 | |
| 7 | PFE |
Pfizer Inc
|
13,097 | $315,375 | |
| 8 | GSK |
GSK plc
|
5,455 | $285,951 |
All Filings in OGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,954 | 18,165 | Shares | Sole | 2026-08-10 | |
| 2022-12-31 | $437,663 | 15,670 | Shares | Sole | 2023-01-31 | |
| No filing history on record for this holder in this stock. | ||||||